The text discusses non-metastatic colon cancer treatment options, including chemotherapy with 5-fluorouracil or capecitabine. It also mentions a study evaluating the effectiveness of riluzole in preventing peripheral neuropathies induced by oxaliplatin. Additionally, it outlines protocols for adjuvant chemotherapy for stage III colon cancer, including LV5FU2 and FOLFOX4 regimens.